본 연구는 우리나라에서 정부 R&D 지원이 기업의 R&D 투자에 미치는 영향에 대해 실증적으로 분석한다. 이를 위해 2012년부터 코로나 직전인 2019년까지 8년 간 『연구 개발활동조사』와 『국가연구개발사업 조사·분석』 그리고 기업 재무정보를 제공하는 『KIS-Value』를 연계하여 패널 자료를 구축하고, 정부 R&D 지원을 받은 기업의 R&D 투자에 미치는 영향을 성향점수매칭법(PSM)과 패널 이중차분법(DID)을 사용하여 추정한다. PSM-패널DID 분석 결과 정부 R&D 지원을 받은 기업은 그렇지 않은 기업과 비교하여 유의한 수준에서 R&D 투자를 확대하는 것으로 확인되었다. 세부 집단별로 살펴보면 정부 R&D 지원 횟수가 커질수록 기업의 R&D 투자 확대 효과는 더 커지며, 정부 R&D 지원금 규모가 일정 수준 이상인 경우에만 기업의 R&D 투자 확대 효과가 유의한 것으로 나타났다. 이러한 결과는 우리나라에서 기업에 대한 정부 R&D 지원은 민간 R&D 투자의 시장실패를 보완하는 본연의 역할을 하고 있으며, 실질적인 정책 효과를 내기 위해서는 중장기적인 관점에서 일정 규모 이상의 지원이 뒷받침되어야 한다는 것을 시사한다.

The effects of R&D investment on innovation such as patents and intangible assets, and the effect on the corporate performance such as revenue and profit growth, were analyzed using path analysis. In particular, this study compared and analyzed the performances of non-cooperative R&D and cooperative R&D. The results of this study are summarized as follows. First, R&D investment has a significant impact on innovation performance. This supports the existing research results. Second, patents have a significant impact on intangible asset growth. Third, in the case of corporate groups carrying out cooperative R&D, intangible asset growth forms a significant causal relationship with revenue growth. Fourth, in case of cooperative R&D, intangible asset growth has a significant mediating effect between patent and revenue growth. Like the existing research, the results of this research support the innovation performance of R&D investment. It also supports the existing argument that the results of cooperative R&D are more favorable to increase corporate value. However, unlike the existing research, we found a path leading to increased revenue through patents and intangible assets, and confirmed that such a path is likely to be achieved through cooperative R & D rather than internal R&D.

The study examines lagged economic effects of research and development (R&D) investment on the market value of manufacturing firms listed on the Shanghai Stock Exchange or the Shenzhen Stock Exchange in China. This study applies panel data analysis methods to address the following issues: 1) There might be an adjustment lag in the impact of R&D investment on corporate market value, and 2) Unobserved firm effects must be taken into account. The balanced panel data includes a total of 1,462 observations with 34 cross-sections of manufacturing firms listed on Chinese stock markets and with 27 time-specific quarterly periods from 2007 to 2017. The results indicate that the R&D investment of Chinese manufacturing firms tends to yield favorable market value of the firm with some adjustments to time. The results show that R&D investment exhibits a strong positive impact on their market value of manufacturing firms in Chinese stock markets. Moreover, R&D investment has a positive time-lag effect on the market value of the firm. Interestingly, the R&D investment of Chinese manufacturing firms generate a relatively constant positive effect on their market value, supporting the notion that the corresponding returns of R&D investment for such firms yield lagged but added market values.